389 related articles for article (PubMed ID: 12966593)
1. Increased degradation of tryptophan in blood of patients with rheumatoid arthritis.
Schroecksnadel K; Kaser S; Ledochowski M; Neurauter G; Mur E; Herold M; Fuchs D
J Rheumatol; 2003 Sep; 30(9):1935-9. PubMed ID: 12966593
[TBL] [Abstract][Full Text] [Related]
2. Tryptophan degradation in patients with gynecological cancer correlates with immune activation.
Schroecksnadel K; Winkler C; Fuith LC; Fuchs D
Cancer Lett; 2005 Jun; 223(2):323-9. PubMed ID: 15896467
[TBL] [Abstract][Full Text] [Related]
3. Tryptophan degradation in multiple trauma patients: survivors compared with non-survivors.
Ploder M; Spittler A; Schroecksnadel K; Neurauter G; Pelinka LE; Roth E; Fuchs D
Clin Sci (Lond); 2009 Apr; 116(7):593-8. PubMed ID: 18986303
[TBL] [Abstract][Full Text] [Related]
4. Increasing production of homocysteine and neopterin and degradation of tryptophan with older age.
Frick B; Schroecksnadel K; Neurauter G; Leblhuber F; Fuchs D
Clin Biochem; 2004 Aug; 37(8):684-7. PubMed ID: 15302611
[TBL] [Abstract][Full Text] [Related]
5. High serum tryptophan concentration in pollinosis patients is associated with unresponsiveness to pollen extract therapy.
Kositz C; Schroecksnadel K; Grander G; Schennach H; Kofler H; Fuchs D
Int Arch Allergy Immunol; 2008; 147(1):35-40. PubMed ID: 18446051
[TBL] [Abstract][Full Text] [Related]
6. Decreased serum tryptophan concentration predicts poor prognosis in malignant melanoma patients.
Weinlich G; Murr C; Richardsen L; Winkler C; Fuchs D
Dermatology; 2007; 214(1):8-14. PubMed ID: 17191041
[TBL] [Abstract][Full Text] [Related]
7. Increased serum kynurenine/tryptophan ratio correlates with disease progression in lung cancer.
Suzuki Y; Suda T; Furuhashi K; Suzuki M; Fujie M; Hahimoto D; Nakamura Y; Inui N; Nakamura H; Chida K
Lung Cancer; 2010 Mar; 67(3):361-5. PubMed ID: 19487045
[TBL] [Abstract][Full Text] [Related]
8. Bariatric surgery cannot prevent tryptophan depletion due to chronic immune activation in morbidly obese patients.
Brandacher G; Winkler C; Aigner F; Schwelberger H; Schroecksnadel K; Margreiter R; Fuchs D; Weiss HG
Obes Surg; 2006 May; 16(5):541-8. PubMed ID: 16687019
[TBL] [Abstract][Full Text] [Related]
9. Tryptophan degradation increases with stage in patients with rheumatoid arthritis.
Schroecksnadel K; Winkler C; Duftner C; Wirleitner B; Schirmer M; Fuchs D
Clin Rheumatol; 2006 May; 25(3):334-7. PubMed ID: 16261283
[TBL] [Abstract][Full Text] [Related]
10. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.
Schefold JC; Zeden JP; Fotopoulou C; von Haehling S; Pschowski R; Hasper D; Volk HD; Schuett C; Reinke P
Nephrol Dial Transplant; 2009 Jun; 24(6):1901-8. PubMed ID: 19155537
[TBL] [Abstract][Full Text] [Related]
11. Enhanced tryptophan degradation in systemic lupus erythematosus.
Widner B; Sepp N; Kowald E; Ortner U; Wirleitner B; Fritsch P; Baier-Bitterlich G; Fuchs D
Immunobiology; 2000 Apr; 201(5):621-30. PubMed ID: 10834318
[TBL] [Abstract][Full Text] [Related]
12. Enhanced tryptophan degradation in patients with ovarian carcinoma correlates with several serum soluble immune activation markers.
Sperner-Unterweger B; Neurauter G; Klieber M; Kurz K; Meraner V; Zeimet A; Fuchs D
Immunobiology; 2011 Mar; 216(3):296-301. PubMed ID: 20822828
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms dependent on tryptophan catabolism regulate immune responses in primary Sjögren's syndrome.
Pertovaara M; Raitala A; Uusitalo H; Pukander J; Helin H; Oja SS; Hurme M
Clin Exp Immunol; 2005 Oct; 142(1):155-61. PubMed ID: 16178870
[TBL] [Abstract][Full Text] [Related]
14. High activity of indoleamine 2,3 dioxygenase enzyme predicts disease severity and case fatality in bacteremic patients.
Huttunen R; Syrjänen J; Aittoniemi J; Oja SS; Raitala A; Laine J; Pertovaara M; Vuento R; Huhtala H; Hurme M
Shock; 2010 Feb; 33(2):149-54. PubMed ID: 19487973
[TBL] [Abstract][Full Text] [Related]
15. Tryptophan degradation and serum neopterin concentrations in intensive care unit patients.
Girgin G; Sahin TT; Fuchs D; Yuksel O; Kurukahvecioglu O; Sare M; Baydar T
Toxicol Mech Methods; 2011 Mar; 21(3):231-5. PubMed ID: 21247367
[TBL] [Abstract][Full Text] [Related]
16. Measurement of tryptophan, kynurenine and neopterin in women with and without postpartum blues.
Kohl C; Walch T; Huber R; Kemmler G; Neurauter G; Fuchs D; Sölder E; Schröcksnadel H; Sperner-Unterweger B
J Affect Disord; 2005 Jun; 86(2-3):135-42. PubMed ID: 15935232
[TBL] [Abstract][Full Text] [Related]
17. Tryptophan catabolism in females with irritable bowel syndrome: relationship to interferon-gamma, severity of symptoms and psychiatric co-morbidity.
Fitzgerald P; Cassidy Eugene M; Clarke G; Scully P; Barry S; Quigley Eamonn MM; Shanahan F; Cryan J; Dinan Timothy G
Neurogastroenterol Motil; 2008 Dec; 20(12):1291-7. PubMed ID: 18823288
[TBL] [Abstract][Full Text] [Related]
18. Indoleamine 2,3-dioxygenase activity of acute myeloid leukemia cells can be measured from patients' sera by HPLC and is inducible by IFN-gamma.
Corm S; Berthon C; Imbenotte M; Biggio V; Lhermitte M; Dupont C; Briche I; Quesnel B
Leuk Res; 2009 Mar; 33(3):490-4. PubMed ID: 18639339
[TBL] [Abstract][Full Text] [Related]
19. Kynurenine pathway in psychosis: evidence of increased tryptophan degradation.
Barry S; Clarke G; Scully P; Dinan TG
J Psychopharmacol; 2009 May; 23(3):287-94. PubMed ID: 18562404
[TBL] [Abstract][Full Text] [Related]
20. Effects of adalimumab therapy on disease activity and interferon-γ-mediated biochemical pathways in patients with rheumatoid arthritis.
Kurz K; Herold M; Winkler C; Klotz W; Russe E; Fuchs D
Autoimmunity; 2011 May; 44(3):235-42. PubMed ID: 21434757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
